ArticleInternational journal of clinical oncology2021

Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents.

Hirotsugu Uemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.